A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

An investigational anti-clotting medication, asundexian, has demonstrated a reduction in the risk of a second ischemic ...

A drug selected for the latest round of Medicare drug price negotiations stands to get dropped because a lower-cost biosimilar version of it is slated to hit the market this year.

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...

Across the spectrum of human afflictions—from cancer to heart disease to rare genetic conditions—medical investigators are continually attempting to break new ground by developing better methods of ...

A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

Here's what to know about TrumpRx, including how it works, who can use it, and how much money it can save.

ACCORDINGLY. BACK TO YOU, MY FRIEND. THANKS, CORY. FOR MANY WOMEN, HOT FLASHES AND NIGHT SWEATS CAN MAKE MENOPAUSE A REAL CHALLENGE. THE FDA JUST APPROVED A NEW NON-HORMONAL DRUG TO HELP KOAT UNM ...

RFK Jr. says TrumpRX will launch "probably in the next 10 days." What we know about how buying medicine, getting discounts on ...